Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Recs

0
Player Avatar RazorSphinx (< 20) Submitted: 4/28/2011 7:31:45 AM : Outperform Start Price: $8.30 ARIA Score: +103.38

Magic Formula

Report this Post Reply

Featured Broker Partners


Advertisement